1-(3-Methyl-1-phenyl-5-pyrazolyl)piperazine

Holiness Pharmaceutical is a trusted and leading pharmaceutical intermediate exporter, supplier and manufacturer of 1-(3-Methyl-1-phenyl-5-pyrazolyl)piperazine, a key piperazine–pyrazole advanced intermediate used in the synthesis of Tenaligliptin API, a DPP-4 inhibitor for diabetes management. We supply high-purity intermediates to pharmaceutical manufacturers across 40+ international markets, supporting regulated and semi-regulated API production.

Globally, Holiness Pharmaceutical is recognized among reliable Tenaligliptin intermediate manufacturers, offering consistent chemical purity, controlled substitution patterns, and stable physicochemical properties essential for antidiabetic drug synthesis. Our expertise in piperazine and heterocyclic intermediates positions us as a dependable pharmaceutical intermediate exporter from India.

Our advanced intermediate manufacturing facilities operate in strict compliance with international quality standards including:
➡ DCGI, WHO-GMP aligned, and cGMP guidelines,
ensuring validated synthetic routes, batch-to-batch consistency, full traceability, and comprehensive quality documentation.

We export this intermediate from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting API manufacturers focused on antidiabetic and metabolic disorder therapies.

Holiness Pharmaceutical Ltd. is a fully integrated organization engaged in route scouting, heterocyclic synthesis, process optimization, commercial-scale manufacturing, and global supply of advanced pharmaceutical intermediates.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.